Example: Heart Attack

Search clinical trials for: Girls Can...Move!

Total 6088 results

NCT06340490

Not yet recruiting

A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus
NCT04150029

Terminated

A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy (STIMULUS-AML1)

Acute Myeloid Leukemia
NCT04656847

Completed

PRIDE. Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/Perindopril (PRIDE)

Myocardial Infarction | Coronary Artery Disease | Arterial Hypertension
NCT02853799

Completed

Comparison of the Effects of Intermittent and Continuous Enteral Feeding on Glucose-Insulin Dynamics in Critically Ill Medical Patients

Glucose-insulin Dynamics
NCT04063449

Unknown

Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC

Non-squamous Non-small Cell Lung Cancer
NCT03799913

Unknown

MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Ovarian Cancer
NCT03193203

Completed

Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male Subjects

Healthy
NCT07489989

Recruiting

Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.

Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
NCT07072234

Recruiting

Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma

Phase 1 | Clear Cell Carcinoma | Growth Factor
NCT07052305

Recruiting

NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma

Large B-cell Lymphoma
NCT07010523

Recruiting

Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Mesothelin-positive Advanced Malignant Solid Tumors
NCT04796675

Recruiting

Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies

Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | Non Hodgkin's Lymphoma
NCT04637620

Recruiting

NMDA Modulation in Major Depressive Disorder

Major Depressive Disorder
NCT05428969

Active, not recruiting

A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies (BEXMAB)

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Relapsed/Refractory AML
NCT07049016

Completed

Comparing CAD/CAM vs Composite for Carious Hypomineralized Molars Evaluating Clinical Outcomes of Both Treatments.

Molar Incisor Hypomineralization
NCT02570451

Completed

Preoperative Cognitive Screening of Surgical Patients 65 Years of Age or Older

Mild Cognitive Impairment
NCT02844062

Unknown

Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme

Glioblastoma Multiforme
NCT02634021

Withdrawn

Effect of Loading of Midazolam or Dexmedetomidine on Hemodynamics

Knee Injuries
NCT02109965

Terminated

The Effect of Dexmedetomidine on Microcirculation in Severe Sepsis

Severe Sepsis
NCT01508455

Completed

Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age

Anesthesia
NCT01519167

Completed

Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation

Ultrasound | CT Scans | MRIs
NCT02080169

Unknown

Safety and Efficacy of Combined Sedation With Midazolam and Dexmedetomidine in ICU Patients

Delirium
NCT01748630

Completed

Effects of Dexmedetomidine on the Postoperative Experience in Children

Failed Moderate Sedation During Procedure
NCT00886275

Completed

Comparing the Effect of Dexmedetomidine With Midazolam on Sedation, Oxidative Stress, and Microcirculation in Intensive Care Unit

Oxidative Stress | Sedation
NCT07120607

Not yet recruiting

Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia

Leukemia
NCT06101082

Recruiting

A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors

Solid Tumor
NCT06010095

Not yet recruiting

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

Recurrent Nasopharyngeal Carcinoma | Stage IV Nasopharyngeal Carcinoma AJCC v8 | Metastatic Nasopharyngeal Carcinoma
NCT05654077

Recruiting

EBV CAR-T Cells for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
NCT05451615

Recruiting

Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis

Rheumatoid Arthritis | Treatment Compliance | Abatacept
NCT04715217

Recruiting

Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma

Lymphoma, B-Cell
NCT02830724

Recruiting

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

Melanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Renal Cell Cancer
NCT03646461

Terminated

Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC

Head and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck
NCT07108140

Terminated

Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

Solid Tumor
NCT02932956

Active, not recruiting

Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) (GAP)

Liver Cancer
NCT02749526

Terminated

Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial

Esophageal
NCT04511832

Completed

Comparative Effectiveness of Acupuncture and Nonsteroidal Anti-inflammatory Drugs for the Management of Aromatase Inhibitor Induced Arthralgia Among Breast Cancer Survivors

Breast Cancer
NCT05300373

Enrolling by invitation

Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunoglobulin E

Adenosine Deaminase Deficiency
NCT04243954

Completed

Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

Cancer Pain
NCT03780959

Completed

Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)

Juvenile Rheumatoid Arthritis
NCT03173417

Completed

Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)

Leukemia
NCT02277197

Completed

Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma, Head And Neck | Carcinoma, Squamous Cell of Head and Neck
NCT03713918

Unknown

Clini Asses of Retentn,Pt Satisfactn and Recurrent Caries of Endocrs Versus Post Crs Using Reinforced Lithium Silicate

Endodontically Treated Teeth
NCT01715896

Completed

A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis
NCT00302367

Completed

An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects

Healthy Volunteers
NCT00717600

Unknown

Bacteriuria Eradication Through Probiotics (BERP)

Bacteriuria
NCT06542887

Not yet recruiting

Black Seed Oil in ADHD

ADHD
NCT06026319

Recruiting

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Follicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Non-hodgkin Lymphoma | High-grade B-cell Lymphoma | Grade 3b Follicular Lymphoma | Relapsed Non-Hodgkin Lymphoma
NCT05020444

Recruiting

TriPRIL CAR T Cells in Multiple Myeloma

Multiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in Relapse
NCT05008536

Recruiting

Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma

Multiple Myeloma, Refractory
NCT04796688

Recruiting

Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies

B-cell Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphoblastic Leukemia

Search clinical trials for: Girls Can...Move!

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations